On 10 October 2010, Autumn Eagle entered into various sale and purchase agreements (“SPAs”) with seven vendors in total whereby the vendors agreed to sell and Autumn Eagle agreed to purchase, on the terms and conditions set out in the SPAs, 319,312,200 issued ordinary shares in the capital of Biosensors (the “Sale Shares”), representing approximately 29.47 per cent. of the issued share capital of Biosensors. The consideration for the Sale Shares was arrived at after taking into account the average price of the shares of Biosensors traded for the 45-day period prior to the date of the SPAs.
A Chasing Sunsets Fund – A Better Way to Plan Nice-to-Haves in Financial
Independence.
-
One of the spending needs that many of you would consider as part of the
income needs for your financial independence (FI) or FIRE, is to have
enough mon...
1 week ago
No comments:
Post a Comment